These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10661677)

  • 1. Dopamine receptor responsivity in alcoholic patients before and after detoxification.
    Markianos M; Moussas G; Lykouras L; Hatzimanolis J
    Drug Alcohol Depend; 2000 Jan; 57(3):261-5. PubMed ID: 10661677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in dopamine receptor responsivity during alcohol detoxification may predict relapse.
    Markianos M; Lykouras L; Moussas G; Hatzimanolis J
    Drug Alcohol Depend; 2001 Nov; 64(3):363-5. PubMed ID: 11672950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of dopamine neurotransmission on the development of ethanol dependence and course of abstinence syndrome].
    Samochowiec J
    Ann Acad Med Stetin; 1994; 40():195-217. PubMed ID: 7503446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of haloperidol on measures of craving and impaired control in alcoholic subjects.
    Modell JG; Mountz JM; Glaser FB; Lee JY
    Alcohol Clin Exp Res; 1993 Apr; 17(2):234-40. PubMed ID: 8488960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin and thyrotropin responses to thyrotropin-releasing hormone and metoclopramide in men with chronic alcoholism.
    Röjdmark S; Adner N; Andersson DE; Austern J; Lamminpää K
    J Clin Endocrinol Metab; 1984 Oct; 59(4):595-600. PubMed ID: 6434573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period.
    George MS; Tenebäck CC; Malcolm RJ; Moore J; Stallings LE; Spicer KM; Anton RF; Ballenger JC
    Alcohol Clin Exp Res; 1999 Jun; 23(6):1077-84. PubMed ID: 10397294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prolactin in the alcohol withdrawal syndrome. Role of the dopaminergic system].
    Nardoni A; Marchetti E; Geatti O; Di Piazza V; Rossi G
    Minerva Med; 1984 Dec; 75(47-48):2833-8. PubMed ID: 6521953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The brain dopamine receptors in chronically alcoholized animals with different relationships to alcohol].
    Bondarenko TT; Vekshina NL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):168-71. PubMed ID: 1316008
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum prolactin correlates with depressed mood during alcohol withdrawal.
    Miller F; Barasch A; Sacks M; Levitan J; Ashcroft L
    Drug Alcohol Depend; 1986 Jul; 17(4):331-8. PubMed ID: 3757769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The neuroendocrine aspects of chronic alcoholism: the effect of alcohol intake and its withdrawal].
    Fonzi S; Murialdo G; Bo P; Filippi U; Costelli P; Parodi C; Maurelli M; Polleri A; Savoldi F
    Ann Ital Med Int; 1992; 7(2):87-94. PubMed ID: 1467129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
    Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
    Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-mediated dopaminergic function after ethanol withdrawal.
    Black RF; Hoffman PL; Tabakoff B
    Alcohol Clin Exp Res; 1980 Jul; 4(3):294-7. PubMed ID: 6105829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin responses to haloperidol in drug-free and treated schizophrenic patients.
    Markianos M; Sakellariou G; Bistolaki E
    J Neural Transm Gen Sect; 1991; 83(1-2):37-42. PubMed ID: 2018629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol withdrawal syndrome: clinical and hormonal responses to alpha 2-adrenergic agonist treatment.
    Cushman P; Sowers JR
    Alcohol Clin Exp Res; 1989 Jun; 13(3):361-4. PubMed ID: 2568765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in dopamine receptor sensitivity in humans after heavy alcohol intake.
    Balldin J; Alling C; Gottfries CG; Lindstedt G; Långström G
    Psychopharmacology (Berl); 1985; 86(1-2):142-6. PubMed ID: 2862656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased GH responsiveness to dopamine receptor stimulation in alcohol addicts during the late withdrawal syndrome.
    Annunziato L; Amoroso S; Di Renzo G; Argenzio F; Aurilio C; Grella A; Quattrone A
    Life Sci; 1983 Dec; 33(26):2651-5. PubMed ID: 6664211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome.
    Peters DH; Faulds D
    Drugs; 1994 Jun; 47(6):1010-32. PubMed ID: 7521826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine receptor responsivity in schizophrenic patients before and after switch from haloperidol to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychiatry Res; 1999 Dec; 89(2):115-22. PubMed ID: 10646830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine measures of dopaminergic function in chronic cocaine users.
    Lee MA; Bowers MM; Nash JF; Meltzer HY
    Psychiatry Res; 1990 Aug; 33(2):151-9. PubMed ID: 2243892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.